Evidence map›Paper›PMID 40764746›Full record

ArticleCommunications chemistry2025

Leveraging tree-transformer VAE with fragment tokenization for high-performance large chemical model generation.

Tensei Inukai, Aoi Yamato, Manato Akiyama, Yasubumi Sakakibara

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tensei InukaiDepartment of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, Japan.ORCID http://orcid.org/0000-0002-6896-2965
Aoi YamatoDepartment of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, Japan.
Manato AkiyamaDepartment of Data Science, Kitasato University School of Frontier Engineering, Sagamihara, Kanagawa, Japan.
Yasubumi SakakibaraDepartment of Biosciences and Informatics, Keio University, Yokohama, Kanagawa, Japan. sakakibara.yasubumi@kitasato-u.ac.jp.ORCID http://orcid.org/0000-0002-6932-3452

Funding

Ministry of Education, Culture, Sports, Science and Technology (MEXT) 23H04880
6 · The paper itself

Abstract

Molecular generation models, especially chemical language model (CLM) utilizing SMILES, a string representation of compounds, face limitations in handling large and complex compounds while maintaining structural accuracy. To address these challenges, we propose the Fragment Tree-Transformer based VAE (FRATTVAE), which treats molecules as tree structures with fragments as nodes. FRATTVAE incorporates several innovative techniques to enhance molecular generation. Molecules are decomposed into fragments and organized into tree structures, allowing for efficient handling of large and complex compounds. Tree positional encoding assigns unique positional information to each fragment, preserving hierarchical relationships. The Transformer's self-attention mechanism models complex dependencies among fragments. This architecture allows FRATTVAE to surpass existing methods, making it a robust solution that is scalable to unprecedented dataset sizes and molecular complexities. Distribution learning across various benchmark datasets, from small molecules to natural compounds, showed that FRATTVAE consistently achieved high accuracy in all metrics while balancing reconstruction accuracy and generation quality. In molecular optimization tasks, FRATTVAE generated high-quality, stable molecules with desired properties, avoiding structural alerts. These results highlight FRATTVAE as a robust and versatile solution for molecular generation and optimization, making it well-suited for a variety of applications in cheminformatics and drug discovery.

Identifiers

PMID40764746
PMCPMC12325745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.